Asymchem Schedules 20 Aug 2026 EGM to Vote on Dual Share Incentive Plans and Shanghai Biotech Capital Injection

Bulletin Express07-31 23:05

Asymchem Laboratories (Tianjin) Co., Ltd. (Asymchem; HK: 06821) has issued a notice convening its third extraordinary general meeting (EGM) of 2026 for 2:00 p.m. on Thursday, 20 August 2026 at the company’s Tianjin headquarters (No. 71, 7th Street, Economic-Technological Development Area). Shareholders will be asked to vote on five special resolutions and one ordinary resolution.

Key agenda items

1. 2026 H-share incentive scheme 2. Board authorisation to administer the 2026 H-share scheme 3. 2026 A-share incentive scheme 4. Assessment Management Measures linked to the 2026 A-share scheme 5. Board authorisation to administer the 2026 A-share scheme 6. Proposed capital contribution to Shanghai Asymchem Biotechnology Development (ordinary resolution)

Shareholder arrangements

• Entitlement: Holders of H-shares recorded on the company’s register as of Thursday, 20 August 2026 may attend and vote. • Book closure: The H-share register will be closed from Monday, 17 August to Thursday, 20 August 2026 (both days inclusive). • Share transfer deadline: Documents must reach Computershare Hong Kong Investor Services by 4:30 p.m. on Friday, 14 August 2026. • Proxy submission: Completed proxy forms must be lodged by 2:00 p.m. on Wednesday, 19 August 2026 (Hong Kong time). • Voting method: All resolutions will be decided by poll in line with Hong Kong Listing Rules.

Board composition

As at the notice date (3 August 2026), the board comprises nine directors: Executive Directors Dr. Hao Hong (Chairperson and CEO), Yang Rui, Zhang Da, and Hong Liang; Non-executive Directors Dr. Ye Song and Zhang Ting; Independent Non-executive Directors Dr. Sun Xuejiao, Dr. Hou Xinyi, and Xie Weikai.

The company advises shareholders to bear their own travel and accommodation costs when attending the half-day meeting. Further details on each resolution are available in the circular dated 3 August 2026, accessible on the Hong Kong Stock Exchange and company websites.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment